Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7998db51a23102cc88e26c8891e7f4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bcf6432cf5b2ddbdc2c29128156559e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfc0feefd21b64246e8889161a4a1f9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cca032b921dfe5c74df391cc8a0143a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50a97c0f4cf261609bac1d2f375c4193 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
filingDate |
2008-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7edee2660b619ec24eeeb13572f5986f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23c96eb53a27b578710fdd37b545c96d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03af8119dad975b07e62f6b48a23be60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4aa687fbed4745703e9bccf867f2eb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6875136016fd6c4cfdeec1c03e577c66 |
publicationDate |
2009-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009068243-A1 |
titleOfInvention |
Novel formulations for delivery of antiviral peptide therapeutics |
abstract |
Provided herein are compositions and methods for their administration as therapeutic agents. In particular, provided herein are compositions and their use for the administration of antiviral peptide therapeutics. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010261876-A1 |
priorityDate |
2007-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |